Bo Medical-B (02142.HK) spent 6.4994 million Hong Kong dollars on May 4 to repurchase 500,000 shares.

Wealth Finance APP announced that Kobio Pharmaceuticals-B (02142.HK) will spend 6.4994 million Hong Kong dollars to repurchase 500,000 shares on May 4, 2026; in accordance with the stock incentive plan adopted and approved by the company's shareholders on November 23, 2020, 41,000 ordinary shares were issued to meet the stock incentive.